Using Bayesian Decision Theory in Dose-Escalation Studies

Statistical Methods for Dose-Finding Experiments

Volumn , Issue , 2006, Pages 149-171

  Whitehead, John ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Bayesian dose escalation procedure; Dose escalation based on Bayesian decision methodology; Gain functions; Safety constraints and stopping rules; Software 'Bayesian ADEPT'; Two parameter logistic regression model; Using Bayesian decision theory

Indexed keywords

REGRESSION ANALYSIS;

BAYESIAN; BAYESIAN DECISION; BAYESIAN DECISION THEORY; DOSE ESCALATION; GAIN FUNCTION; LOGISTIC REGRESSION MODELING; STOPPING RULE;

DECISION THEORY;

EID: 77955150520     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470861258.ch7     Document Type: Chapter

References (27)

1. L. Edler (2001) Overview of phase I trials, in Statistics in Clinical Oncology (ed. J. Crowley), Marcel Dekker, New York, pp. 1-34.
2. T. B. Dougherty,V.H. Porche and P. F. Thall (2000) Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesia. Anesthesiology, 92, 1010-16.
3. J. O'Quigley, M. Pepe and L. Fisher (1990) Continual reassessment method: a practical design for phase I clinical trials in cancer. Biometrics, 46, 33-48.
4. D. Faries (1994) Practical modifications of the continual reassessment method for phase I cancer clinical trials. J. Biopharmaceutical Statistics, 4, 147-64.
5. E.L. Korn, D. Midthune, T.T. Chen, L.V. Rubinstein, M.C. Christian and R.M. Simon (1994) A comparison of two phase I designs. Statistics in Medicine, 13, 1799-806.
6. S.N. Goodman, M.L. Zahurak and S. Piantadosi (1995) Some practical improvements in the continual reassessment method for phase I studies. Statistics in Medicine, 14, 1149-61.
7. S. Piantadosi and G. Liu (1996) Improved designs for dose escalation studies using pharmacokinetic measurements. Statistics in Medicine, 15, 1605-18.
8. A. Legedza and J.G. Ibrahim (2001) Heterogeneity in phase I clinical trials: prior elicitation and computation using the continual reassessment method. Statistics in Medicine, 20, 867-82.
9. J. O'Quigley and L.Z. Shen (1996) Continual reassessment method: a likelihood approach. Biometrics, 52, 673-84.
10. J. O'Quigley (2001) Dose-finding designs using continual reassessment method, in Statistics in Clinical Oncology (ed. J. Crowley), Dekker, New York, pp. 35-72.
11. W. F. Rosenberger and L. M. Haines (2002) Competing designs for phase I clinical trials: a review. Statistics in Medicine, 21, 2757-70.
12. J. Babb, A. Rogatko and S. Zacks (1998) Cancer phase I clinical trials: efficient dose escalation with overdose control. Statistics in Medicine, 17, 1103-20.
13. M. Gasparini and J. Eisele (2000) A curve-free method for phase I clinical trials. Biometrics, 56, 609-15.
14. J. Whitehead and H. Brunier (1995) Bayesian decision procedures for dose determining experiments. Statistics in Medicine, 14, 885-93.
15. J. Whitehead and D. Williamson (1998) An evaluation of Bayesian decision procedures for dose-finding studies. J. Biopharmaceutical Medicine, 8, 445-67.
16. C. Gatsonis and J.B. Greenhouse (1992) Bayesian methods for phase I clinical trials. Statistics in Medicine, 11, 1377-89.
17. J. Whitehead, Y. Zhou, S. Patterson, N.D. Webber and S. Francis (2001) Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers. Biostatistics, 2, 47-61.
18. Y. Zhou (2004) Choice of designs and doses for early phase trial. Fundamental Clin. Pharmacology, 18, 1-7.
19. Y. Zhou and J. Whitehead (2003) Practical implementation of Bayesian dose escalation procedure. Drug Information J., 37, 45-59.
20. D. Collett (ed.) (2003) Modelling Binary Data, 2nd edn, Chapman and Hall/CRC, Florida.
21. R.K. Tsutakawa (1975) Technical Report 52, Mathematical Sciences, University of Missouri, Columbia, Missouri.
22. O. Wang and D.E. Faries (2000) A two-stage dose selection strategy in phase I trials with wide dose ranges. J. Biopharmaceutical Statistics, 10, 319-33.
23. S. Patterson, S. Francis, M. Ireson, D.Webber and J. Whitehead (1999) A novel Bayesian decision procedure for early-phase dose finding studies. J. Biopharmaceutical Statistics, 9, 583-97.
24. J. Whitehead, Y. Zhou, N. Stallard, S. Todd and A. Whitehead (2001) Learning from previous responses in phase I dose-escalation studies. Br. J. Clin. Pharmacology, 52, 1-7.
25. J. Whitehead, Y. Zhou, J. Stevens, G. Blakey, J. Price and J. Leadbetter (2006) Bayesian decision procedures for dose-escalation based on evidence of undesirable events and therapeutic benefit. Statistics in Medicine, 25, 37-53.
26. J. Whitehead, Y. Zhou, J. Stevens and G. Blakey (2006) An evaluation of a Bayesian method of dose-escalation based on bivariate binary responses, Statistics in Medicine, 25, 433-445.
27. Y. Zhou and J. Whitehead (2002) Bayesian Adept: Operating Manual. The University of Reading, Reading, UK.